 A central research aim in synthetic biology is to modify gene regulatory pathways so as to control biochemical reactions and produce biochemicals of societal value. For example, genetically modified microorganisms can work as biosensors that detect toxic chemicals or help clean up contaminated soil and water by metabolizing toxic compounds (Khalil &amp; Collins 2010). Many efforts are also directed towards improvements of biomedical research and clinical practices, e.g., through diagnostic tools, and personalized cancer treatments (Christiansen 2016b). Products of synthetic biology that are already commercially available include biomedical compounds used in treatments against diabetes and malaria, nitrogen fertilizers, and flavouring substances for “bleeding” plant-based burgers (Voigt 2020). Most prominently, the fast development of effective synthetic mRNA vaccines against Covid-19 points to the potential of synthetic biology in supporting “pandemic preparedness” (Vickers and Freemont 2022), although these developments draw on molecular techniquest that precede the field of synthetic biology. 